Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of H5N1 Pandemic Influenza Vaccine in Children
NCT00370864Phase 2Completed
- Sponsor
- CSL Seqirus
- Start
- Sep 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant influenza ha vaccine (h5n1) in Avian Influenza (AI), sponsored by CSL Seqirus. Started Sep 2006; status: completed.
02
Drugs
recombinant influenza ha vaccine (h5n1)
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT00370864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370864.